2010 Program Description
An annual conference targeting individuals actively engaged clinically or scientifically in diagnostic and therapeutic radiology, oncology, surgery, gynecology, family practice and genetics.

The optimal management of breast cancer is rapidly evolving. A multidisciplinary team of medical, surgical, and radiation oncologists, pathologists, plastic surgeons and genetic counselors are routinely involved in offering treatment recommendations for individual patients with a diagnosis of breast cancer. With the emergence of prevention strategies, women at high risk of developing breast cancer are now evaluated for medical therapies, surgical options and lifestyle changes that may reduce their risk of developing breast cancer. The 12th Annual Lynn Sage Breast Cancer Symposium provides a forum for discussing and presenting laboratory and clinical research concerning the care of patients with breast cancer.

2010 Educational Objectives
At the conclusion of this symposium participants should be able to:

1. Discuss the controversies regarding the pathological assessment following neoadjuvant systemic therapy

2. Explain clinical implications of unusual pathological diagnoses

3. Interpret new insights into genetics of breast cancer

4. Describe prevention strategies for decreasing risk of developing breast cancer

5. Explain the controversies regarding the recent U.S. Public Health Service recommendations regarding mammography screening

6. Discuss the impact of new imaging studies for staging

7. Describe contemporary breast reconstruction techniques

8. Discuss novel agents targeting important biologic pathways for breast cancer

9. Interpret clinical issues related to post-mastectomy radiation therapy

10. Discuss the surgical issues related to management of DCIS

11. Describe molecular markers related to development and progression of DCIS

12. Discuss the evidence supporting the role of bisphosphonates as adjuvant therapy of breast cancer